Subscribe: MedWorm: Chronic Obstructive Pulmonary
http://www.medworm.com/rss/medicalfeeds/conditions/Chronic-Obstructive-Pulmonary.xml
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
chronic obstructive  chronic  copd  disease  health  obstructive pulmonary  patients  pulmonary disease  pulmonary  source 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: MedWorm: Chronic Obstructive Pulmonary

MedWorm: Chronic Obstructive Pulmonary News



MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Chronic Obstructive Pulmonary



Last Build Date: Fri, 20 Apr 2018 23:41:29 +0100

 



Barbara Bush Leaves A Legacy: Champion For End-Of-Life Care

Fri, 20 Apr 2018 12:49:00 +0100

Before her passing earlier this week, former First Lady Barbara Bush announced that she would be spending her final days at home with her family utilizing “comfort care” in lieu of continued medical treatment for her congestive heart failure and COPD. She chose quality of life over quantity of life. (Source: Forbes.com Healthcare News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Trial Backs Triple-Drug Inhaler for COPD (CME/CE)

Thu, 19 Apr 2018 20:35:00 +0100

(MedPage Today) -- But study design criticized by journal editor (Source: MedPage Today Allergy)



COPD: Working together clinical audit 2017

Thu, 19 Apr 2018 14:14:11 +0100

This report, summarising data from 36,341 hospital admissions, finds various improvements, however the time to delivery of non-invasive ventilation, prescribing of oxygen, recording of spirometry, and delivery of inpatient smoking cessation pharmacotherapy require attention. (Source: Current Awareness Service for Health (CASH))



Triple Therapy Tied to Reduced Rate of COPD Exacerbations

Wed, 18 Apr 2018 19:00:45 +0100

WEDNESDAY, April 18, 2018 -- For patients with chronic obstructive pulmonary disease (COPD), triple therapy is associated with a reduced rate of exacerbations, according to a study published online April 18 in the New England Journal of... (Source: Drugs.com - Pharma News)



Temple spinout HGE Health broadens audience for its telemedicine technology

Wed, 18 Apr 2018 16:13:40 +0100

Initially developed to better monitor and manage COPD patients, the Philadelphia company's technology is now also being used with patients who have idiopathic pulmonary fibrosis. (Source: bizjournals.com Health Care News Headlines)



Former First Lady Barbara Bush Dies

Tue, 17 Apr 2018 22:08:44 +0100

Former first lady Barbara Bush, who had COPD and congestive heart failure, died at the age of 92. (Source: WebMD Health)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




AstraZeneca inks outcomes-based contract with Highmark for COPD, asthma drug

Tue, 17 Apr 2018 14:15:55 +0100

Health insurer Highmark inked an outcomes-based contract with AstraZeneca (NYSE:AZN) for Symbicort, the pharmaceutical company’s drug designed to treat asthma and chronic obstructive pulmonary disease. Highmark said its contract with AstraZeneca is one of the first outcomes-based deals involving a respiratory drug and will apply to commercial members of its national and core markets in Pennsylvania, West Virginia and Delaware. Get the full story at our sister site, Drug Delivery Business News. The post AstraZeneca inks outcomes-based contract with Highmark for COPD, asthma drug appeared first on MassDevice. (Source: Mass Device)



COPD Now Afflicts More Women Than Men In US COPD Now Afflicts More Women Than Men In US

Mon, 16 Apr 2018 21:08:15 +0100

Barbara Bush ’ s case highlights that chronic obstructive pulmonary disease (COPD) — a disease linked to long-term smoking and traditionally considered a men ’ s disease — is now more prevalent among women.Kaiser Health News (Source: Medscape Medical News Headlines)



‘Scary’ Lung Disease Now Hits More Women Than Men

Mon, 16 Apr 2018 12:45:18 +0100

Chronic obstructive pulmonary disease (COPD), linked to long-term smoking, has traditionally been considered a men’s disease. But data show it is now more prevalent among women — in large part because they embraced smoking much later than men did. (Source: WebMD Health)



Quitting Smoking, Nationwide Health, COPD Predictors: It's PodMed Double T! (with audio)

Sat, 14 Apr 2018 18:35:00 +0100

(MedPage Today) -- This week's topics include safety of smoking cessation medicines, a nationwide look at health, predictors of COPD in childhood, and neuron growth and health in one part of the brain (Source: MedPage Today Allergy)



Respiratory nurses highlight staffing concerns in COPD care

Thu, 12 Apr 2018 00:47:00 +0100

Nurses and others working for pulmonary rehabilitation services have seen staffing levels drop and their workload increase amid fears they are struggling to offer timely support to those who desperately need it. (Source: Nursing Times)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Poor Lung Function in Early Life Ups COPD Risk (CME/CE)

Thu, 12 Apr 2018 00:35:00 +0100

(MedPage Today) -- Impact of childhood risk factors aggravated by later-life smoking (Source: MedPage Today Allergy)



Tai Chi Helps Improve Respiratory Function in COPD

Tue, 10 Apr 2018 17:00:00 +0100

Tai chi found to be as effective as pulmonary rehabilitation (Source: Pulmonary Medicine News - Doctors Lounge)



Research suggests alternative treatment for beta blocker intolerant heart attack patients

Tue, 10 Apr 2018 04:00:00 +0100

(New York Institute of Technology) Beta blockers have become a prescription drug staple for recovering heart attack patients. However, these blood pressure-reducing medications cannot be tolerated by many patients who are at higher risk for developing cardiovascular disease, including those with chronic obstructive pulmonary disease (COPD) and asthma, the elderly, and diabetics. As seen in the March 26 issue of Thyroid, researchers at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) now pose a new treatment for patients with beta blocker intolerance: thyroid hormone therapy. (Source: EurekAlert! - Medicine and Health)



5 Key Takeaways from Mesothelioma Expert Teleconference

Mon, 09 Apr 2018 18:26:05 +0100

If you have been diagnosed with mesothelioma, you’re likely seeking information and resources to learn more about the disease. A free one-hour mesothelioma teleconference is a great place to start. CancerCare recently hosted the “Advancements in the Treatment of Mesothelioma” workshop. The session featured five mesothelioma experts, including Dr. Hedy Kindler, director of the mesothelioma program at the University of Chicago Comprehensive Cancer Center. The Mesothelioma Applied Research Foundation co-sponsored the teleconference, which is available online for free. All mesothelioma patients can benefit from the topics covered, including an overview of the disease, treatment options, importance of clinical trials, how to communicate with your health care team and other important issu...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




AstraZeneca taps Owlstone ’ s breath biopsy device to identify asthma, COPD biomarkers

Mon, 09 Apr 2018 12:55:42 +0100

Pharmaceutical giant AstraZeneca (NYSE:AZN) inked a deal with Owlstone Medical to use the diagnostics company’s breath biopsy device to identify biomarkers for asthma and chronic obstructive pulmonary disease, the companies announced today. Owlstone’s ReCiva breath sampler, which has CE Mark clearance in the E.U., captures volatile organic compounds in a patient’s breath. A VOC profile can be used to non-invasively diagnose disease at a very early stage and monitor treatment response, according to Owlstone. Get the full story at our sister site, Drug Delivery Business News. The post AstraZeneca taps Owlstone’s breath biopsy device to identify asthma, COPD biomarkers appeared first on MassDevice. (Source: Mass Device)



COPD Patients May Breathe Easier With Tai Chi

Mon, 09 Apr 2018 09:04:06 +0100

MONDAY, April 9, 2018 -- People struggling with COPD might find some relief in an ancient art. The centuries-old practice of tai chi appears to boost the exercise capabilities and the quality of life of those with chronic obstructive pulmonary... (Source: Drugs.com - Daily MedNews)



Medical News Today: COPD: Tai chi a 'viable alternative' to standard treatment

Mon, 09 Apr 2018 07:00:00 +0100

Researchers conducted a randomized trial that examined the benefits of tai chi for people living with chronic obstructive pulmonary disease. (Source: Health News from Medical News Today)



COPD Patients May Breathe Easier With Tai Chi

Mon, 09 Apr 2018 07:00:00 +0100

Title: COPD Patients May Breathe Easier With Tai ChiCategory: Health NewsCreated: 4/9/2018 12:00:00 AMLast Editorial Review: 4/9/2018 12:00:00 AM (Source: MedicineNet Lungs General)



Study: Almost 100 million adults have COPD in China

Mon, 09 Apr 2018 04:00:00 +0100

(Tulane University) Chronic obstructive pulmonary disease (COPD) is widespread in China with 8.6 percent of the country's adult population -- almost 100 million people -- suffering from the chronic lung disease, according to a new Tulane University study published in The Lancet. The study, which provided lung-function screenings for more than 50,990 participants, is the largest survey of COPD across age groups ever conducted in China. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Origins of Adult Killer COPD May Lie in Childhood

Fri, 06 Apr 2018 14:15:18 +0100

Two new studies suggest COPD could have roots in life's earliest years. (Source: WebMD Health)



COPD Is an Adult Killer, But Its Origins May Lie in Childhood

Fri, 06 Apr 2018 09:00:25 +0100

FRIDAY, April 6, 2018 -- COPD may seem like an adult disease, often tied to smoking. But two new studies suggest it could have roots in life's earliest years. Kids with issues such as asthma or those exposed to secondhand smoke may be more... (Source: Drugs.com - Daily MedNews)



Most COPD cases 'linked to childhood risk factors like asthma'

Fri, 06 Apr 2018 00:36:00 +0100

Most cases of chronic obstructive pulmonary disease (COPD) can be linked to factors in childhood, according to a major new study, which highlights the need for early intervention and prevention. (Source: Nursing Times)



Three-quarters of COPD cases are linked to childhood risk factors that are exacerbated in adulthood

Thu, 05 Apr 2018 22:59:00 +0100

Three-quarters of chronic obstructive pulmonary disease (COPD) cases have their origins in poor lung function pathways beginning in childhood. These pathways are associated with exposures in childhood, and amplified by factors in adulthood, according to a cohort study published in The Lancet Respiratory Medicine journal. (Source: University of Bristol news)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Sunrise Labs executes succession plan | Personnel Moves – April 5, 2018

Thu, 05 Apr 2018 20:54:35 +0100

Medical device and life science development group Sunrise Labs said this week that it completed its succession plan, with president Eric Soederberg acquiring the majority of shares in the company through a stock sale with founder and board chair Drew Sunstein. With the transaction, the Bedford, N.H.-based company said that it secured its planned ownership succession, and added that founder Sunstein will retain a minority stock position in the company and will remain active within it. Details of the transaction were not disclosed. Soederberg joined Sunrise in 2008, and prior to joining served as a programs executive director at KMC Systems. He also held positions at DEKA Research and Development, and helped lead the development of the iBot mobility system. “I love working with innovat...



Novel MRI technique explains asthma issues

Thu, 05 Apr 2018 07:00:00 +0100

Canadian researchers at Western University and McMaster University are working...Read more on AuntMinnie.comRelated Reading: Genetic variation in lung airways elevates risk of COPD MRI contrast agent could aid inflammation imaging MRI technique may help diagnose migraine headaches Advanced visualization tool assesses lung disease MRI shows pancreatic inflammation in diabetics (Source: AuntMinnie.com Headlines)



National asthma and COPD audit programme

Thu, 05 Apr 2018 00:00:00 +0100

A new national asthma and COPD audit programme (NACAP) was launched on 1 March 2018. It adds adult and paediatric asthma to the former national COPD audit programme. (Source: NHS Networks)



The Mortality Risk Factor of CAP Patients With COPD The Mortality Risk Factor of CAP Patients With COPD

Wed, 04 Apr 2018 04:14:57 +0100

A new study examines the mortality risk factors among COPD patients hospitalized with community acquired pneumonia.BMC Pulmonary Medicine (Source: Medscape Today Headlines)



Practicing Tai Chi helps improve respiratory function in patients with COPD

Wed, 04 Apr 2018 04:00:00 +0100

(Elsevier) Currently, pulmonary rehabilitation (PR) is used where available to improve exercise capacity and quality of life, but the treatment requires access to trained staff and specialized facilities. A new study in the journal CHEST ® looked at Tai Chi as a lower cost, more easily accessed treatment option. Investigators found that this slow, methodical form of exercise is equivalent to PR for improving respiratory function in patients with COPD. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Man Sues Railroad Company For COPD From Chemical Exposure, Seeks More Than $75,000

Tue, 03 Apr 2018 20:20:13 +0100

URBANA, Ill. - A former railroad worker on March 20 filed a lawsuit in Illinois federal court seeking damages in excess of $75,000 for chronic obstructive pulmonary disease (COPD) he contends was caused by exposure to "harmful, hazardous and toxic chemicals" of various kinds while on the job (Scott Tague v. Illinois Central Railroad Company, No. 18-2089, C.D. Ill.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)



UC scientist patents drug to treat dangerous infections

Tue, 03 Apr 2018 16:32:47 +0100

Daniel Hassett, a scientist with the University of Cincinnati College of Medicine, has been issued a patent for a drug that is could be used to treat lung infections in patients with cystic fibrosis or chronic obstructive pulmonary disease. The drug known as AB569 was developed in the lab of Hassett, a professor in the UC Department of Molecular Genetics, Biochemistry and Microbiology.  It targets many antibiotic-resistant organisms that cause pulmonary infections in patients with cystic fibrosis… (Source: bizjournals.com Health Care:Physician Practices headlines)



ResMed is disrupting connected health: Here ’ s how

Tue, 03 Apr 2018 15:48:12 +0100

The AirMini, the smallest PAP available, was released by ResMed in 2017. [Image courtesy of ResMed] Here’s how a respiratory firm took control of the connected health and the medtech digital revolution. When you think powerful digital connected devices, the first thing to pop into your head probably isn’t a CPAP. Continuous positive airway pressure has been shown in numerous studies to be effective in improving sleep apnea and preventing a host of co-morbidities such as obesity, congestive heart failure and chronic obstructive pulmonary disease. But the buy-in from patients is notoriously lacking. Respiratory companies have been struggling with this challenge for many years. Designers and developers have made both iterative and innovative improvements, without demonstrably moving the ...



Sunovion launches inhaled COPD therapy in U.S.

Tue, 03 Apr 2018 14:45:54 +0100

Sunovion Pharmaceuticals launched its Lonhala Magnair drug in the U.S. for the long-term maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary disease, the company reported today. Sunovion touts its drug as the first nebulized long-acting muscarinic antagonist approved to treat COPD in the U.S. The product is delivered using the Magnair nebulizer system, which is designed to administer medication in two to three minutes. Get the full story at our sister site, Drug Delivery Business News. The post Sunovion launches inhaled COPD therapy in U.S. appeared first on MassDevice. (Source: Mass Device)



Ask What Are the Four Stages of COPD

Tue, 03 Apr 2018 07:00:00 +0100

What Are the Four Stages of COPD? (Source: eMedicineHealth.com)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Ask What Happens in the Last Stages of COPD

Tue, 03 Apr 2018 07:00:00 +0100

What Happens in the Last Stages of COPD? (Source: eMedicineHealth.com)



Ask Can a Person With COPD Get Better

Mon, 02 Apr 2018 07:00:00 +0100

Can a Person With COPD Get Better? (Source: eMedicineHealth.com)



Simple Lung Function Tests in Primary Care Help ID Early COPD

Sat, 31 Mar 2018 00:00:00 +0100

Peak flow meter, microspirometry are optimal, with full spirometry for positive results (Source: Pulmonary Medicine News - Doctors Lounge)



Effective rehabilitation in COPD

Thu, 29 Mar 2018 04:00:00 +0100

(Deutsches Aerzteblatt International) By 2020, COPD will be the third most common cause of morbidity and mortality worldwide. In the current issue of Deutsches Ä rzteblatt International (Dtsch Arztebl Int 2018; 115: 117-23), the group of authors led by Rainer Gloeckl investigates the question to which extent pulmonary rehabilitation can contribute to improving the quality of life of persons with COPD. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




New research award by Fisher & Paykel healthcare to benefit COPD patients

Thu, 29 Mar 2018 04:00:00 +0100

(American Thoracic Society) The ATS Foundation is pleased to announce the new ATS Foundation/Fisher& Paykel Healthcare Research Award in Respiratory Support with Nasal High Flow (NHF) in Patients with COPD. The award will provide funding for two years in the amount of $100,000. (Source: EurekAlert! - Medicine and Health)



2018 Medtech Startup Showdown: The Finals

Wed, 28 Mar 2018 19:15:56 +0100

They fought off some stiff competition, and now we have the final two competitors in MD+DI's 2018 Medtech Startup Showdown. It's down to a battle of digital health dynamos Strados Labs vs. Spry Health, and once again, we're asking you to help us decide which upstart medtech company has what it takes to make it in the real world. You know the drill by now: We'll give readers a week to vote, and the company that gets the most votes is the winner. We'll feature the champ in an upcoming profile on MD+DI (see complete rules here). strados_vs_spry.png Company name Strados Labs Spry Health     Describe your device and how it will benefit healthcare.                           Strados Labs makes the first and only always-on health device and platform ...



Mortality After Hospitalization for a COPD Exacerbation Mortality After Hospitalization for a COPD Exacerbation

Wed, 28 Mar 2018 04:14:53 +0100

Find out which factors may be associated with an increase in mortality among patients hospitalized for COPD exacerbations in the previous year.BMC Pulmonary Medicine (Source: Medscape Today Headlines)



Convexity Scientific launches pocket-sized nebulizer

Tue, 27 Mar 2018 20:10:53 +0100

Convexity Scientific announced today that the company launched its Flyp nebulizer for patients with asthma and chronic obstructive pulmonary disease. The handheld, pocket-sized device was approved by the FDA in May last year. Convexity’s nebulizer includes a vibrating internal disk that produces an inhaled aerosol mist to deliver medication deep into patients’ lungs. Get the full story at our sister site, Drug Delivery Business News.  The post Convexity Scientific launches pocket-sized nebulizer appeared first on MassDevice. (Source: Mass Device)



Convexity Scientific Receives FDA Clearance For Its FLYP(TM) Nebulizer, Unveils The New Device At Medtrade Spring

Tue, 27 Mar 2018 15:50:59 +0100

Lightweight, Pocket-Portable Nebulizer Poised to Lead the Next Generation in Respiratory Disease Care and Treatment LAS VEGAS, March 27, 2018 -- (Healthcare Sales & Marketing Network) -- Following its FDA clearance in May 2017, today, Convexity Scienti... Devices, FDA, Product Launch Convexity Scientific, FLYP, nebulizer, asthma, COPD (Source: HSMN NewsFeed)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




University of Cincinnati researcher receives US patent for potential COPD treatment

Tue, 27 Mar 2018 04:00:00 +0100

(University of Cincinnati Academic Health Center) A researcher in the University of Cincinnati (UC) College of Medicine has been granted a US patent for a potential treatment for a pulmonary infection in patients with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).The treatment, known as AB569, was developed in the lab of Daniel Hassett, PhD, a professor in the UC Department of Molecular Genetics, Biochemistry and Microbiology. (Source: EurekAlert! - Medicine and Health)



Risk of fall in patients with COPD - Hakamy A, Bolton CE, Gibson JE, McKeever TM.

Mon, 26 Mar 2018 13:42:07 +0100

A matched cohort study was conducted to determine the incidence of falls in patients following a diagnosis of COPD using a UK primary care database. 44 400 patients with COPD and 175  545 non-COPD subjects were identified. The incidence rate of fall per 1... (Source: SafetyLit)



Limb Muscle Dysfunction After Acute Exacerbation of COPD Limb Muscle Dysfunction After Acute Exacerbation of COPD

Mon, 26 Mar 2018 13:37:00 +0100

There are no short cuts when it comes to managing limb muscle dysfunction associated with acute exacerbation of chronic obstructive pulmonary disease.Medscape Critical Care (Source: Medscape Today Headlines)



New research opens door for potential treatment of deadly lung disease

Wed, 21 Mar 2018 13:19:30 +0100

When COPD patients encounter the bacterium H. influenzae, the results can be fatal. A new study offers critical insight into treatment. (Source: Yale Science and Health News)



Postop Pulmonary Complications in Asthma and COPD Patients Postop Pulmonary Complications in Asthma and COPD Patients

Wed, 21 Mar 2018 04:14:54 +0100

Which factors may be predictive of postoperative pulmonary complications among patients with pulmonary diseases?BMC Pulmonary Medicine (Source: Medscape Today Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Study of COPD patients has created a 'looking glass' into genome of pathogen

Mon, 19 Mar 2018 04:00:00 +0100

(University at Buffalo) Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Administration WNY Healthcare System have yielded extraordinary information about the pathogen that does the most harm to patients. The results, published this week in Proceedings of the National Academy of Sciences, provide the first insights into how this pathogen lives and adapts to its host in real time over months and even years. (Source: EurekAlert! - Medicine and Health)



With big data, researchers identify new targets for lung disease treatments

Mon, 19 Mar 2018 04:00:00 +0100

(University of Maryland School of Medicine) Every year, approximately 12 million adults in the US are diagnosed with Chronic Obstructive Pulmonary Disease, and 120,000 die from it. For people with COPD, Haemophilus influenzae, a bacterium, can be particularly dangerous. Now, researchers have unraveled how the bacterium adapts quickly, which may open new avenues for therapy for COPD and other diseases such as ear infections or pneumonia. (Source: EurekAlert! - Infectious and Emerging Diseases)



Genetic variant discovery to help asthma sufferers

Fri, 16 Mar 2018 04:00:00 +0100

(University of Liverpool) Research from the University of Liverpool, published in Lancet Respiratory Medicine, identifies a genetic variant that could improve the safety and effectiveness of corticosteroids, drugs that are used to treat a range of common and rare conditions including asthma, and chronic obstructive pulmonary disease (COPD). (Source: EurekAlert! - Medicine and Health)



COPD and Rural Health: A Dialogue on the National Action Plan

Thu, 15 Mar 2018 17:29:33 +0100

March 19, 2018 8:30am-5:00pm ET. (Source: HSR Information Central)



Urban-Rural County and State Differences in COPD Urban-Rural County and State Differences in COPD

Mon, 12 Mar 2018 05:14:54 +0100

How do the rates and outcomes of COPD differ between urban and rural residents in the United States?Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




BODE may overestimate transplant benefit in COPD patients

Tue, 06 Mar 2018 05:00:00 +0100

(American College of Chest Physicians) In a new study published in the journal CHEST ® , researchers aimed to determine if patients selected as transplant candidates have a better survival rate than the BODE score indicates. (Source: EurekAlert! - Infectious and Emerging Diseases)



Inhaled Triple Therapy Reduces COPD Exacerbations Inhaled Triple Therapy Reduces COPD Exacerbations

Mon, 05 Mar 2018 23:06:10 +0100

Inhaled triple therapy, consisting of inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta2-agonist, reduces exacerbations in patients with severe chronic obstructive pulmonary disease (COPD), compared with dual bronchodilator therapy, according to results from the TRIBUTE trial.Reuters Health Information (Source: Medscape Allergy Headlines)



Owlstone Medical raises $15m to commercialize breath biopsy platform

Mon, 05 Mar 2018 18:19:46 +0100

Owlstone Medical touted today that it raised $15 million to support the commercialization of its breathalyzer diagnostic device. Funds from the round, co-led by Horizons Ventures and Aviva Ventures, will also be used to expand the company’s pipeline and the precision medicine services that it provides to the pharma industry, according to the Cambridge, England-based company. Owlstone Medical’s breath biopsy platform is designed to measure volatile organic compounds in a person’s breath as a means to diagnose particular diseases. The company has collaborated with Cancer Research U.K. to launch a study evaluating the early detection of eight types of cancer using its breathalyzer. Owlstone also inked a deal with GlaxoSmithKline (NYSE:GSK) last year to incorporate the compa...



A COPD Pop Quiz: 5 Tricky Questions

Sat, 03 Mar 2018 00:19:16 +0100

Try these 5 questions written by a pulmonologist and based on updates to the GOLD guidelines on how to classify and manage COPD. (Source: ConsultantLive)



Progressive Dyspnea & amp; Chronic Cough: One Disease or Two?

Fri, 02 Mar 2018 19:48:25 +0100

Beth is age 52, smokes 2 packs of cigarettes a day, gets breathless in cold weather, and has had " bronchitis " twice this year. What's your diagnosis? (Source: ConsultantLive)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




‘ Western ’ Diet Associated With Respiratory Symptoms, COPD

Fri, 02 Mar 2018 18:00:00 +0100

Western dietary pattern associated with higher prevalence of wheeze, cough, phlegm (Source: Pulmonary Medicine News - Doctors Lounge)



EU Panel Backs Two Triple Combo Drugs for COPD Maintenance EU Panel Backs Two Triple Combo Drugs for COPD Maintenance

Fri, 23 Feb 2018 21:12:17 +0100

CHF 5993 and Trydonis, from Chiesi Farmaceutici SpA, combine a glucocorticoid, a long-acting beta-2 receptor agonist, and a long-acting muscarinic antagonist.International Approvals (Source: Medscape Medical News Headlines)



Treatment with Novartis' Ultibro ® Breezhaler® improved cardiac function in COPD patients with lung hyperinflation

Thu, 22 Feb 2018 20:58:55 +0100

Novartis today announced the publication of the CLAIM* study in the Lancet Respiratory Medicine, which demonstrated that treatment once-daily Ultibro® Breezhaler® (indacaterol/glycopyrronium 110/50 mcg) significantly improved lung and cardiac function, when compared to placebo, in chronic obstructive pulmonary disease (COPD) patients with lung hyperinflation[1]. (Source: World Pharma News)



Urban-Rural County and State Differences in Chronic Obstructive Pulmonary Disease — United States, 2015

Thu, 22 Feb 2018 18:00:00 +0100

(Source: CDC Morbidity and Mortality Weekly Report)



Safety of Tiotropium in Children with Persistent Asthma

Tue, 20 Feb 2018 16:12:32 +0100

Results of the first study to evaluate use of the adult COPD drug in children age 5 years and younger lay fertile ground for future trials. (Source: ConsultantLive)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Study: COPD robot improves medication adherence, but no effect on admissions

Mon, 19 Feb 2018 17:10:28 +0100

A socially assistive robot could be key to helping people with COPD manage their condition at home. A recent study published in JMIR, found that COPD patients that had a take-home a robot following a hospitalization were more likely to adhere to their medications and complete their rehabilitation excercises than their peers that did not have a robot.   (Source: mobihealthnews)



Moderate and severe exacerbations accelerate physical activity decline in COPD patients

Mon, 19 Feb 2018 05:00:00 +0100

(Barcelona Institute for Global Health (ISGlobal)) A study published in the European Respiratory Journal has shown that both moderate and severe exacerbations in COPD patients are associated with a decline in their physical activity level. Researchers observed tha the acute drop in physical activity during a COPD exacerbation has an important and lasting effect. (Source: EurekAlert! - Medicine and Health)



Long - Term Inhaled Corticosteroid Use May Raise Fracture Risk

Fri, 16 Feb 2018 18:00:00 +0100

Long - term inhaled corticosteroid use for COPD tied to small increased risk of hip, upper extremity fracture (Source: Pulmonary Medicine News - Doctors Lounge)



GSK seeks expanded label for Trelegy Ellipta inhaler in EU

Wed, 14 Feb 2018 15:08:05 +0100

GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) have submitted data to the European Medicines Agency in the hopes of expanding the label for its once-daily, triple combination inhaler, Trelegy Ellipta. The drug-device combo was approved in Europe in November last year as a maintenance treatment for adult patients with moderate to severe chronic obstructive pulmonary disease who are not adequately treated by a inhaled corticosteroid combined with a long-acting beta-adrenergic agonist. GSK and Innoviva hope that data from its Impact trial will support the product’s use in a broader population of COPD patients who are at risk of exacerbation. Get the full story at our sister site, Drug Delivery Business News. The post GSK seeks expanded label for Trelegy Ellipta inhaler in EU a...



Widely Used COPD Meds Tied to Increased Fracture Risk

Wed, 14 Feb 2018 07:00:00 +0100

Title: Widely Used COPD Meds Tied to Increased Fracture RiskCategory: Health NewsCreated: 2/13/2018 12:00:00 AMLast Editorial Review: 2/14/2018 12:00:00 AM (Source: MedicineNet Lungs General)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Antibiotics for Treatment of Acute Exacerbation of COPD Antibiotics for Treatment of Acute Exacerbation of COPD

Wed, 14 Feb 2018 05:14:52 +0100

Are antibiotics a safe and effective therapeutic option for COPD patients with acute exacerbation?BMC Pulmonary Medicine (Source: Medscape Today Headlines)



Widely Used COPD Meds Tied to Higher Fracture Risk

Tue, 13 Feb 2018 18:15:07 +0100

COPD -- often linked to smoking -- is a combination of emphysema and chronic bronchitis. It is a progressive, debilitating illness that currently has no cure. (Source: WebMD Health)



Widely Used COPD Meds Tied to Increased Fracture Risk

Tue, 13 Feb 2018 18:00:00 +0100

(Source: Pulmonary Medicine News - Doctors Lounge)



Dual Bronchodilation Has Safe Cardiac Profile in COPD Dual Bronchodilation Has Safe Cardiac Profile in COPD

Fri, 09 Feb 2018 20:35:31 +0100

Dr Nicholas Gross on a large meta-analysis that sought to determine whether mixing two different classes of bronchodilators increases mortality.Medscape Pulmonary Medicine (Source: Medscape Today Headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




COPD risk: Clues from the tree branches

Thu, 08 Feb 2018 00:00:00 +0100

(Source: ScienceNOW)



Long-Term Use of Inhaled Steroids May Up Fracture Risk in COPD (CME/CE)

Wed, 07 Feb 2018 17:30:00 +0100

(MedPage Today) -- Patients could benefit from regular monitoring for BMD, fracture risk (Source: MedPage Today Allergy)



Study: Long-term use of inhaled corticosteroids may heighten risk of bone fractures in COPD patients

Tue, 06 Feb 2018 20:03:19 +0100

Researchers reported this month that in men and women with chronic obstructive pulmonary disease, long-term use of inhaled corticosteroids may be linked to an increased risk of bone fractures. Previous research has shown that the inhaled drugs, used to treat COPD, impact bone mineral density based on the dose of the corticosteroid, especially in post-menopausal women. Get the full story at our sister site, Drug Delivery Business News. The post Study: Long-term use of inhaled corticosteroids may heighten risk of bone fractures in COPD patients appeared first on MassDevice. (Source: Mass Device)



COPD (Chronic Obstructive Pulmonary Disease) Symptoms, Causes, Stages, Life Extpectancy

Tue, 06 Feb 2018 07:00:00 +0100

Title: COPD (Chronic Obstructive Pulmonary Disease) Symptoms, Causes, Stages, Life ExtpectancyCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/6/2018 12:00:00 AM (Source: MedicineNet Lungs General)



COPD (Chronic Obstructive Pulmonary Disease) Symptoms, Causes, Stages, Life Expectancy

Tue, 06 Feb 2018 07:00:00 +0100

Title: COPD (Chronic Obstructive Pulmonary Disease) Symptoms, Causes, Stages, Life ExpectancyCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/6/2018 12:00:00 AM (Source: MedicineNet Lungs General)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Lung operation that could make you breathe more easily

Tue, 06 Feb 2018 01:27:02 +0100

Around 1.3 million people in the UK have chronic obstructive pulmonary disease and a new trial at the Royal Brompton and Glenfield Hospital in Leicester hopes to bring surgery to more patients. (Source: the Mail online | Health)



Long-term usage of inhaled corticosteroids may increase risk of bone fractures in patients with COPD

Mon, 05 Feb 2018 05:00:00 +0100

(American College of Chest Physicians) A study published in the February journal CHEST ® suggests long-term inhaled corticosteroids (ICS) in patients with COPD may increase risk of bone fractures in both men and women. Previous studies have suggested that ICS negatively impacts bone mineral density in a dose-dependent fashion, particularly affecting postmenopausal women, but it has been unclear whether these effects translate to bone fractures. (Source: EurekAlert! - Medicine and Health)



COPD: Keeping fit during childhood lowers risk of lung disease in later life

Thu, 01 Feb 2018 00:01:00 +0100

KEEPING fit during childhood and as a teenager helps protect people, particularly boys, from lung disease in later life, according to research released today. (Source: Daily Express - Health)



A Medical Director ’s Perspective: Influencing Rehospitalization Rates

Wed, 31 Jan 2018 20:27:34 +0100

Efforts to reduce hospitalizations often focus on identifying specific clinical conditions that contribute to hospitalizations, particularly those that are considered potentially preventable. Potentially preventable hospitalizations result from exacerbation of clinical conditions such as congestive heart failure, chronic obstructive pulmonary disease, or diabetes in which the exacerbation and hospitalization could have been prevented had optimal care been provided. The theory is that by incentivizing providers to focus on specific clinical categories that are likely to contribute to admissions for preventable reasons, we can reduce the overall rate of hospitalization. (Source: Caring for the Ages)



Altered lung structure may increase COPD risk

Tue, 30 Jan 2018 00:00:00 +0100

A study found a link between variations in the structure of the lung ’s airways and the risk of developing chronic obstructive pulmonary disorder, or COPD. (Source: NIH Research Matters from the National Institutes of Health (NIH))

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease

Mon, 29 Jan 2018 23:01:31 +0100

DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Jan. 29, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ( " Theravance Biopharma " ) and Mylan N.V. (NASDAQ, TASE: MYL) ( " Mylan " ) today announced that the U.S. Food and Drug... (Source: Drugs.com - New Drug Applications)



Blood Eosinophil Counts Predict COPD Exacerbations, Response to Steroids Blood Eosinophil Counts Predict COPD Exacerbations, Response to Steroids

Mon, 29 Jan 2018 21:51:05 +0100

Higher blood eosinophil counts are associated with an increased risk of exacerbation and a better chance of responding to inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD), according to a post hoc analysis.Reuters Health Information (Source: Medscape Today Headlines)



FDA to review Theravance ’ s application for once-daily COPD med

Mon, 29 Jan 2018 18:16:44 +0100

The FDA has accepted Theravance Biopharma‘s (NSDQ:TBPH)  marketing application for revefenacin, an inhaled long-acting muscarinic antagonist designed to treat chronic obstructive pulmonary disease. The FDA is slated to make a decision about the once-daily treatment by Nov. 13. Get the full story at our sister site, Drug Delivery Business News. The post FDA to review Theravance’s application for once-daily COPD med appeared first on MassDevice. (Source: Mass Device)



Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease

Mon, 29 Jan 2018 15:28:50 +0100

FDA Assigns PDUFA Target Action Date of November 13, 2018 DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Jan. 29, 2018 -- (Healthcare Sales & Marketing Network) -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Myla... Biopharmaceuticals, FDA Theravance Biopharma, Mylan, Revefenacin, COPD (Source: HSMN NewsFeed)



COPD Drug Tiotropium Shows Promise in Preschoolers With Persistent Asthma COPD Drug Tiotropium Shows Promise in Preschoolers With Persistent Asthma

Fri, 26 Jan 2018 20:36:56 +0100

A new study provides preliminary evidence that tiotropium, a long-acting anticholinergic drug used for chronic obstructive pulmonary disease (COPD), is safe and effective in preschool-age children with asthma symptoms not well controlled by inhaled corticosteroids.Reuters Health Information (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




AstraZeneca's three-in-one inhaler helps COPD patients in trial

Fri, 26 Jan 2018 08:27:35 +0100

(Reuters) - AstraZeneca said an inhaler for chronic obstructive pulmonary disease (COPD) delivered improved lung function in a late stage trial that could challenge GlaxoSmithKline's new three-in-one inhaler. (Source: Reuters: Health)



'COPD school' expands to help keep patients with debilitating lung disease out of hospital

Tue, 23 Jan 2018 16:45:26 +0100

National program teaches patients with chronic obstructive pulmonary disease how to manage symptoms and avoid repeated visits to the hospital. (Source: CBC | Health)



$3.6 million NIH grant to UA-led international research consortium seeks precision medicine solutions

Tue, 23 Jan 2018 05:00:00 +0100

(University of Arizona Health Sciences) Dr. Stefano Guerra, a University of Arizona respiratory therapist, will lead an international effort to target deficits of a specific protein found in lung cells as an indicator of persistence of asthma from childhood into adulthood. Results could lead to personalized therapies for asthma and chronic obstructive pulmonary disease. (Source: EurekAlert! - Medicine and Health)



Genetic Lung Variants May Identify COPD Risk (CME/CE)

Thu, 18 Jan 2018 14:35:04 +0100

(MedPage Today) -- Airway biomarker could also lead to targeted therapy (Source: MedPage Today Primary Care)



Research Associate - Digital Health

Wed, 17 Jan 2018 09:00:00 +0100

Location: Oxford, United Kingdom Job Type: Full-Time Employer: The University of Oxford Closing Date: 12.02.2018 An opportunity has arisen for a researcher to support an established research programme led by Professor Andrew Farmer. You will have responsibility for working on one or more of a series of related studies intended to develop and evaluate new approaches to monitoring and supporting people with long term (and multiple) conditions including diabetes and chronic obstructive pulmonary disease, building on the availability of novel digital-health technologies. (Source: eHealth News EU)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Genetic variation in lung airways elevates risk of COPD

Wed, 17 Jan 2018 07:00:00 +0100

CT scans show that a quarter of the adult population has nonstandard airway...Read more on AuntMinnie.comRelated Reading: AI algorithm predicts lung disease, adverse events on CT COPD severity mirrors lung cancer incidence AJR: Ultralow-dose CT can evaluate COPD Group issues call for best lung cancer, COPD protocols Emphysema-related COPD on CT signals higher malignancy risk (Source: AuntMinnie.com Headlines)



Study: Genetic indicators help determine COPD risk

Tue, 16 Jan 2018 19:19:41 +0100

Researchers have found that genetic variations in lungs help identify people at risk for chronic obstructive pulmonary disease from cigarette smoke, pollution. (Source: Health News - UPI.com)



New study offers insights on genetic indicators of COPD risk

Tue, 16 Jan 2018 13:45:00 +0100

COPD, a progressive disease that makes it hard to breathe, is the fourth leading cause of death in the United States. (Source: National Institutes of Health (NIH) News Releases)



Risk of adverse drug reactions found to be ‘higher for COPD patients’

Mon, 15 Jan 2018 12:13:00 +0100

Patients with chronic obstructive pulmonary disease, especially those who also have other chronic illnesses, are at greater risk of adverse medication reactions, according to a UK primary care study. (Source: Nursing Times)



New therapeutic approach for advanced lung disease

Fri, 12 Jan 2018 05:00:00 +0100

(Ruhr-University Bochum) Researchers have demonstrated the potential of a new class of drugs for the treatment of refractory chronic obstructive pulmonary disease, i.e. COPD. Incurable to date, the disease is one of the most frequent causes of death worldwide and is typically triggered by smoking. In the current preclinical study, two anti-inflammatory substances have proved more effective than preparations used to date. The results were published in the Journal of Allergy and Clinical Immunology. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Addressing the variation in chronic obstructive pulmonary disease

Fri, 12 Jan 2018 00:00:00 +0100

There are considerable opportunities to improve prevention, diagnosis and treatment of people with, or at risk of developing, chronic obstructive pulmonary disease (COPD) within England. (Source: NHS Networks)



Chronic Obstructive Pulmonary Disease (COPD) Pathway

Thu, 11 Jan 2018 14:33:55 +0100

This pathway defines the core components of an optimal service for people with chronic obstructive pulmonary disease (COPD). It includes resources to support local health economise to concentrate their improvement efforts where there is greatest opportunity to address variation and improve population health. It contains a number of key messages for commissioners (Source: Current Awareness Service for Health (CASH))



Home Physical Activity Coaching May Up Physical Activity in COPD

Fri, 05 Jan 2018 18:00:00 +0100

More patients in coaching group were persistently active than those receiving usual care (Source: Pulmonary Medicine News - Doctors Lounge)